Anjali Vekaria is a Dermatology physician. OpenAlex indexes 13 publications with 511 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3400 Old Milton Pkwy Ste C370
Alpharetta, GA 300053747
Telephone
404-737-4500Provider last certified this registry record 2 Sept 2024.
Industry payments
20 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Arcutis Biotherapeutics, Inc.Program year202512 payments
- Regeneron Healthcare Solutions, Inc.Program year20257 payments
- GENZYME CORPORATIONProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
46.2%Azole Antifungal46.2%Ketoconazole100%Part D≥26 patientsDermatology
37.2%Corticosteroid21.8%Triamcinolone Acetonide100%Part D≥12 patientsInterleukin-4 Receptor alpha Antagonist15.4%Dupixent Pen100%Part D<11 patientsSensory organs
16.7%Corticosteroid16.7%Hydrocortisone100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Pilot Study of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Combination Gel in the Treatment of Perimenstrual Acne.
PubMed
2022 - Phase 2 randomized, double-blind study of IL-17 targeting with secukinumab in atopic dermatitis
Journal of Allergy and Clinical Immunology
2020 - Magnesium supplementation in the treatment of pseudoxanthoma elasticum: A randomized trial
Journal of the American Academy of Dermatology
2019 - Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab
Journal of Allergy and Clinical Immunology
2018 - A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
Archives of Dermatological Research
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Hywel C Williams
University of Nottingham
Mohsen Afarideh, MD, MPH
Mayo Clinic
Brigitte Dréno
Centre National de la Recherche Scientifique
Giovanni Damiani
University of Milan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”